{"schema_version":"secwatch.filing_event.v1","accession":"0000950159-23-000227","form_type":"8-K","ticker":"CI","cik":"0001739940","company_name":"Cigna Group","filed_at":"2023-08-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.058310+00:00","generated_at":"2026-06-12T08:50:36.906657+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Cigna Q2 adjusted EPS $6.13, revenue up 7% to $48.6B; raises FY revenue guidance","bullets":["Adjusted income from operations $1.82B ($6.13/share) vs $1.97B ($6.20) YoY, reflecting absence of divested businesses.","Total revenue $48.6B (+7% YoY) driven by Evernorth and Cigna Healthcare growth.","FY 2023 adjusted revenue outlook raised to at least $190B (+$2B); adjusted EPS reaffirmed at least $24.70.","Total medical customers reached 19.5M (+1.5M or +8% from Dec 2022), driven by U.S. Commercial and Medicare Advantage.","FY 2023 cash flow from operations outlook raised to at least $9.5B (+$500M)."],"urls":{"canonical":"https://secwatch.observer/filing/0000950159-23-000227","json":"https://secwatch.observer/filing/0000950159-23-000227.json","markdown":"https://secwatch.observer/filing/0000950159-23-000227.md","text":"https://secwatch.observer/filing/0000950159-23-000227.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1739940/000095015923000227/0000950159-23-000227-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1739940/000095015923000227/cigna8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T08:50:36.906657+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a073e61d163961c50bd18ea16341bb389712bc23","claim":"Cigna Group reported the three months ended June 30, 2023 results: revenue $48.6 billion, net income $1.5 billion, or $4.92 per share. Guidance reaffirmed.","evidence_excerpt":"The Cigna Group Reports Strong Second Quarter 2023 Results • Total revenues in the second quarter were $48.6 billion • Shareholders’ net income for the second quarter was $1.5 billion, or $4.92 per share • Adjusted income from operations 1 for the second quarter was $1.8 billion, or $6.13 per share • 2023 outlook 2 for adjusted income from operations 1,2 is at least $24.70 per share","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1739940/000095015923000227/0000950159-23-000227-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three months ended June 30, 2023"},{"label":"Revenue","value":"$48.6 billion"},{"label":"Net income","value":"$1.5 billion, or $4.92 per share"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}